Compared with normal renal tissue, ALDH3A2 expression is significantly downregulated in ccRCC tissue, where it functions to inhibit tumor progression by modulating the PI3K-AKT pathway [31]. Here, ALDH3A2 is linked to nonpapillary renal cell carcinoma.